Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals Cash on Hand 2010-2023 | JAZZ

Jazz Pharmaceuticals cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Jazz Pharmaceuticals cash on hand for the quarter ending December 31, 2023 was $1.626B, a 84.5% increase year-over-year.
  • Jazz Pharmaceuticals cash on hand for 2023 was $1.626B, a 84.5% increase from 2022.
  • Jazz Pharmaceuticals cash on hand for 2022 was $0.881B, a 49.04% increase from 2021.
  • Jazz Pharmaceuticals cash on hand for 2021 was $0.591B, a 72.27% decline from 2020.
  
Jazz Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2023 $1,626
2022 $881
2021 $591
2020 $2,133
2019 $1,077
2018 $825
2017 $601
2016 $426
2015 $989
2014 $684
2013 $637
2012 $387
2011 $158
2010 $45
2009 $19
Jazz Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $1,626
2023-09-30 $1,586
2023-06-30 $1,362
2023-03-31 $1,168
2022-12-31 $881
2022-09-30 $899
2022-06-30 $771
2022-03-31 $491
2021-12-31 $591
2021-09-30 $672
2021-06-30 $891
2021-03-31 $2,433
2020-12-31 $2,133
2020-09-30 $1,917
2020-06-30 $1,696
2020-03-31 $982
2019-12-31 $1,077
2019-09-30 $1,070
2019-06-30 $883
2019-03-31 $832
2018-12-31 $825
2018-09-30 $1,064
2018-06-30 $815
2018-03-31 $708
2017-12-31 $601
2017-09-30 $453
2017-06-30 $319
2017-03-31 $407
2016-12-31 $426
2016-09-30 $426
2016-06-30 $916
2016-03-31 $981
2015-12-31 $989
2015-09-30 $999
2015-06-30 $922
2015-03-31 $783
2014-12-31 $684
2014-09-30 $575
2014-06-30 $268
2014-03-31 $251
2013-12-31 $637
2013-09-30 $588
2013-06-30 $504
2013-03-31 $451
2012-12-31 $387
2012-09-30 $190
2012-06-30 $155
2012-03-31 $244
2011-12-31 $158
2011-09-30 $113
2011-06-30 $102
2011-03-31 $65
2010-12-31 $45
2010-09-30 $23
2010-06-30 $10
2010-03-31 $20
2009-12-31 $19
2009-09-30 $13
2009-06-30 $17
2009-03-31 $18
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.861B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.985B 28.76
Chugai Pharmaceutical (CHGCY) Japan $54.581B 23.70
Takeda Pharmaceutical (TAK) Japan $41.871B 6.78
Merck (MKGAF) Germany $20.986B 19.80
Astellas Pharma (ALPMY) Japan $16.902B 23.95
Shionogi (SGIOY) Japan $14.275B 12.35
Neurocrine Biosciences (NBIX) United States $13.233B 54.96
Sandoz Group AG (SDZNY) $13.171B 0.00
United Therapeutics (UTHR) United States $10.907B 11.68
Catalent (CTLT) United States $10.095B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.501B 0.00
Ionis Pharmaceuticals (IONS) United States $6.055B 0.00
Revolution Medicines (RVMD) United States $5.970B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.341B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Madrigal Pharmaceuticals (MDGL) United States $4.636B 0.00
Alpine Immune Sciences (ALPN) United States $4.228B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.933B 0.00
Indivior (INDV) United States $2.673B 12.43
Evotec AG (EVO) Germany $2.484B 0.00
Summit Therapeutics (SMMT) United States $2.484B 0.00
Corcept Therapeutics (CORT) United States $2.421B 24.62
Dyne Therapeutics (DYN) United States $2.123B 0.00
PTC Therapeutics (PTCT) United States $1.937B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.834B 18.95
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.776B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.741B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.673B 9.91
Avadel Pharmaceuticals (AVDL) Ireland $1.639B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.581B 27.66
Ardelyx (ARDX) United States $1.561B 0.00
4D Molecular Therapeutics (FDMT) United States $1.368B 0.00
Pacira BioSciences (PCRX) United States $1.249B 12.44
Ironwood Pharmaceuticals (IRWD) United States $1.235B 11.60
Soleno Therapeutics (SLNO) United States $1.227B 0.00
Ocular Therapeutix (OCUL) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.158B 7.12
Xencor (XNCR) United States $1.156B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.106B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.950B 0.00
Sage Therapeutics (SAGE) United States $0.939B 0.00
Cronos Group (CRON) Canada $0.932B 0.00
Cassava Sciences (SAVA) United States $0.909B 0.00
ARS Pharmaceuticals (SPRY) United States $0.886B 0.00
Relay Therapeutics (RLAY) United States $0.884B 0.00
Enliven Therapeutics (ELVN) United States $0.875B 0.00
USANA Health Sciences (USNA) United States $0.831B 13.09
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.723B 0.00
Savara (SVRA) United States $0.713B 0.00
Silence Therapeutics (SLN) United Kingdom $0.636B 0.00
Siga Technologies (SIGA) United States $0.635B 9.40
ProKidney (PROK) United States $0.624B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Verve Therapeutics (VERV) United States $0.597B 0.00
Korro Bio (KRRO) United States $0.589B 0.00
OmniAb (OABI) United States $0.565B 0.00
Altimmune (ALT) United States $0.533B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.530B 0.00
Exscientia (EXAI) United Kingdom $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.501B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.471B 0.00
Larimar Therapeutics (LRMR) United States $0.462B 0.00
Tourmaline Bio (TRML) United States $0.458B 0.00
Heron Therapeutics (HRTX) United States $0.440B 0.00
Harrow (HROW) United States $0.435B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.432B 0.00
Lexeo Therapeutics (LXEO) United States $0.403B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.367B 0.00
Esperion Therapeutics (ESPR) United States $0.362B 0.00
Nature's Sunshine Products (NATR) United States $0.356B 19.91
ESSA Pharma (EPIX) Canada $0.329B 0.00
Fractyl Health (GUTS) United States $0.327B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.325B 0.00
Lyra Therapeutics (LYRA) United States $0.323B 0.00
Metagenomi (MGX) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.297B 0.00
Akebia Therapeutics (AKBA) United States $0.293B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
Black Diamond Therapeutics (BDTX) United States $0.278B 0.00
Adherex Technologies (FENC) United States $0.278B 0.00
Nektar Therapeutics (NKTR) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.273B 0.00
Prelude Therapeutics (PRLD) United States $0.270B 0.00
Nanobiotix S.A (NBTX) France $0.260B 0.00
Foghorn Therapeutics (FHTX) United States $0.257B 0.00
Xeris Biopharma Holdings (XERS) United States $0.253B 0.00
Avita Medical (RCEL) United States $0.249B 0.00
Telomir Pharmaceuticals (TELO) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.225B 0.00
Acrivon Therapeutics (ACRV) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.207B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.191B 0.00
MediWound (MDWD) Israel $0.174B 0.00
Regulus Therapeutics (RGLS) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.156B 0.00
Incannex Healthcare (IXHL) Australia $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.150B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Inotiv (NOTV) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.53
GlycoMimetics (GLYC) United States $0.139B 0.00
Relmada Therapeutics (RLMD) United States $0.138B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.136B 2.87
ProPhase Labs (PRPH) United States $0.133B 0.00
FibroGen (FGEN) United States $0.128B 0.00
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
Eliem Therapeutics (ELYM) United States $0.126B 0.00
OptiNose (OPTN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Vivani Medical (VANI) United States $0.106B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
AlloVir (ALVR) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Journey Medical (DERM) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.076B 6.12
Tempest Therapeutics (TPST) United States $0.074B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Mural Oncology (MURA) $0.066B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.066B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
Gain Therapeutics (GANX) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
JanOne (JAN) United States $0.033B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Nutriband (NTRB) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.031B 0.00
Viracta Therapeutics (VIRX) United States $0.028B 0.00
Aptorum Group (APM) United Kingdom $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
CERo Therapeutics Holdings (CERO) United States $0.027B 0.00
Lipocine (LPCN) United States $0.025B 0.00
DURECT (DRRX) United States $0.024B 0.00
Addex Therapeutics (ADXN) Switzerland $0.024B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.40
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.08
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
BioVie (BIVI) United States $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Clever Leaves Holdings (CLVR) Canada $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Finch Therapeutics (FNCH) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.92
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 46.73